Delisting riskPopularity #4,664
CDIO · NASDAQ · Biotechnology

Cardio Diagnostics (CDIO)

Develops genetic-epigenetic blood tests and clinical intelligence for coronary heart disease.

$1.89
vs last close−0.03 (−1.56%)